Since its inception at the start of the 20th century, radiation therapy has been recognized as an essential element of an effective cancer care program and has become one of the most common forms of treatment for many types of cancer. Approximately fifty percent of cancer patients receive it either alone or in combination with other treatments with remarkable results.
Radiation oncologists from NewYork-Presbyterian Hudson Valley Hospital’s cancer center, Lawrence Koutcher, M.D., and Leah Katz, M.D., MPH, both published experts and researchers on this subject, discuss this type of therapy and how it has raised the bar for more successful patient outcomes.
Adults with schizophrenia have an elevated risk of dying from suicide. Yet there's only limited understanding of when and why people with schizophrenia die of suicide in part because research studies have looked at relatively small groups of patients.
Dear Colleagues, We wanted to take a moment to acknowledge the one-year anniversary of the death of George Floyd and the national and global reckoning.
The presence of the corkscrew-shaped
Borrelia burgdorferi spirochetes in the former Lyme disease patient’s brain and spinal cord were evidence of a persistent infection.
The 69-year-old woman, who experienced progressively debilitating neurological symptoms throughout her illness, decided to donate her brain to Columbia University for the study of the disease as her condition worsened.
While she had first experienced the classic symptoms of Lyme disease 15 years prior and was treated accordingly after her diagnosis, she experienced continual neurological decline including a severe movement disorder and personality changes, and eventually succumbed to Lewy body dementia.
“These findings underscore how persistent these spirochetes can be in spite of multiple rounds of antibiotics targeting them.”
Food and Drug Administration (FDA) has cleared the Pfizer coronavirus (COVID-19) vaccine for use on children under 16.
On Monday, May 10, the FDA extended the emergency use authorization given to the Pfizer-BioNTech COVID-19 vaccine to allow for the vaccination of kids between 12 and 15. This decision will allow middle school students to get vaccinated before the fall.
The emergency use authorization was granted after studies released by Pfizer claiming that the pharma company’s coronavirus vaccine was 100 percent effective in adolescents.
Pfizer’s trial involved 2,260 adolescents between the ages of 12 and 15, with around an even number of people getting the Pfizer vaccine and the placebo. According to the company, there were 18 cases of COVID-19 in the placebo group and zero in the vaccine group, resulting in a 100 percent efficacy in preventing illness. (Related: Two-year-old baby DIES during Pfizer’s COVID-19 vaccine experiments on children.)